COVID-19: The Disease Caused by Novel Coronavirus (2019-nCoV) Given New Name by WHO

The disease caused by the novel coronavirus (2019-nCoV) has been given new name COVID-19 by the international body WHO which makes no reference to any of the people, places or animals associated with this virus.

The disease caused by the deadly novel coronavirus which has claimed thousands lives so far has been given a new name COVID-19

The acronym COVID-19 stands for Corona Virus Disease 2019, as this highly infectious disease was first diagnosed last year.

Under international guidelines, the W.H.O. “has to find a name that does not refer to a geographical location, an animal, an individual or group of people, and which is also pronounceable and related to the disease,”

In keeping with this policy to avoid stigmatising, WHO chose the new name COVID-19 which makes no reference to any of the people, places or animals associated with this virus.

***

Don't miss

Interferon-β for Treatment of COVID-19: Subcutaneous Administration more Effective

Results from the phase2 trial support the view that...

COVID‑19: National Lockdown in the UK

To protect the NHS and save lives., National Lockdown...

A Novel Approach to ‘Repurpose’ Existing Drugs For COVID-19

A combination of biological and computational approach to study...

Did the SARS CoV-2 Virus Originate in Laboratory?

There is no clarity on the natural origin of...

‘Bradykinin Hypothesis’ Explains the Exaggerated Inflammatory Response in COVID-19

A novel mechanism to explain the different unrelated symptoms...

Stay in touch:

92,094FansLike
45,575FollowersFollow
1,772FollowersFollow
51SubscribersSubscribe

Newsletter

Latest

COVID-19 in 2025  

The unprecedented COVID-19 pandemic spanning over three years claimed...

CoViNet: A New Network of Global Laboratories for Coronaviruses 

A new global network of laboratories for coronaviruses, CoViNet,...

COVID-19: Severe lung infection affects heart through “cardiac macrophage shift” 

It is known that COVID-19 increases the risk of...

JN.1 sub-variant: The Additional Public Health Risk Is Low at the Global Level

JN.1 sub-variant whose earliest documented sample was reported on 25...

COVID-19: JN.1 sub-variant has higher transmissibility and immune escape ability 

Spike mutation (S: L455S) is hallmark mutation of JN.1...
SCIEU Team
SCIEU Teamhttps://www.scientificeuropean.co.uk
Scientific European® | SCIEU.com | Significant advances in science. Impact on humankind. Inspiring minds.

20C-US: New Coronavirus Variant in the USA

Researchers at Southern Illinois University have reported a new variant of SARS COV-2 Virus in the USA.   According to reports published on preprint server which is yet to...

Spikevax Bivalent Original/Omicron Booster Vaccine: First Bivalent COVID-19 Vaccine receives MHRA approval  

Spikevax Bivalent Original/Omicron Booster Vaccine, the first bivalent COVID-19 booster vaccine developed by Moderna has received MHRA approval. Unlike the Spikevax Original, the bivalent version...

CD24: an Anti-Inflammatory Agent for Treatment of COVID-19 Patients

The researchers at the Tel-Aviv Sourasky Medical Center have successfully completely Phase I trials for the use of CD24 protein delivered in exosomes to treat COVID-19. Scientists at...